Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hiroaki Ogata, Akiko Takeshima & Hidetoshi Ito. (2022) An update on phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a review of safety profiles. Expert Opinion on Drug Safety 21:7, pages 947-955.
Read now
Read now
Michel Vallée, Jordan Weinstein, Marisa Battistella, Roxanne Papineau, Dianne Moseley & Gordon Wong. (2021) Multidisciplinary Perspectives of Current Approaches and Clinical Gaps in the Management of Hyperphosphatemia. International Journal of Nephrology and Renovascular Disease 14, pages 301-311.
Read now
Read now
Articles from other publishers (16)
Erika Biró, Dániel Erdélyi, Petra Varga, Mária Sinkó, Katalin Bartyik, Gábor Kovács, Gábor Ottóffy, Ferenc Vincze, István Szegedi, Csongor Kiss & Tamás Szabó. (2023) Daily serum phosphate increase as early and reliable indicator of kidney injury in children with leukemia and lymphoma developing tumor lysis syndrome. Pediatric Nephrology 38:9, pages 3117-3127.
Crossref
Crossref
Burak Özkan, Yusuf Koçluk & Burcu Kasım. (2022) Effects of Systemic Diseases on Graft Preparation in Descemet Membrane Endothelial Keratoplasty. Eye & Contact Lens: Science & Clinical Practice 48:12, pages 527-533.
Crossref
Crossref
Susmita Sinha & Mainul Haque. (2022) Obesity, Diabetes Mellitus, and Vascular Impediment as Consequences of Excess Processed Food Consumption. Cureus.
Crossref
Crossref
Rana Bahaa MohammedMohammed Mahmood Mohammed. (2022) Potential role of Niacin as Adjuvant to Sevelamer on Serum levels of Inorganic phosphorus, Calcium and Calcium-phosphorus product in Hemodialysis patients with Hyperphosphatemia. Research Journal of Pharmacy and Technology, pages 2158-2162.
Crossref
Crossref
Shmeylan A. Al Harbi, Hasan M. Al-Dorzi, Albatool M. Al Meshari, Hani Tamim, Sheryl Ann I. Abdukahil, Musharaf Sadat & Yaseen Arabi. (2021) Association between phosphate disturbances and mortality among critically ill patients with sepsis or septic shock. BMC Pharmacology and Toxicology 22:1.
Crossref
Crossref
Yan Zhu, Jinlan Rao, Xueling Liao, Jihong Ou, Wei Li & Chao Xue. (2021) Using iron-based phosphate binders in phosphate reduction and anemia improvement in patients receiving dialysis: a meta-analysis of randomized controlled trials. International Urology and Nephrology 53:9, pages 1899-1909.
Crossref
Crossref
Keizo Nishime, Noriko Sugiyama & Koichi Okada. (2021) A New Disease Concept in the Age of Processed Foods—Phosphorus-Burden Disease; including CKD–MBD Concrete Analysis and the Way to Solution. Nutrients 13:8, pages 2874.
Crossref
Crossref
Shintarou Takayama, Masako Oda & Hiroshi Saitoh. (2021) Investigation of Leftover Hyperphosphatemia Drugs in Hemodialysis OutpatientsInvestigation of Leftover Hyperphosphatemia Drugs in Hemodialysis Outpatients. YAKUGAKU ZASSHI 141:3, pages 433-440.
Crossref
Crossref
Oğuz Özler, Gül Yeşiltepe Mutlu, Mehmet Taşdemir, Şahin Avcı, Ilmay Bilge & Şükrü Hatun. (2020) An 8-month-old infant with hypercalcemia and hyperphosphatemia—Answers. Pediatric Nephrology 36:3, pages 563-566.
Crossref
Crossref
Rana Bahaa Mohammed, Mohammed Mahmood Mohammed & Sfaa Jameel Naeemah. (2020) Clinical Evaluation of Niacin in Hemodialysis Patients with Hyperphosphatemia as Adjuvant to Calcium Carbonate. Al Mustansiriyah Journal of Pharmaceutical Sciences 20:3, pages 82-93.
Crossref
Crossref
Yoshinori Tsuboi, Shuichi Ohtomo, Yasuhiro Ichida, Hitoshi Hagita, Kazuharu Ozawa, Manami Iida, Shunsuke Nagao, Hisashi Ikegami, Tadakatsu Takahashi & Naoshi Horiba. (2020) EOS789, a novel pan-phosphate transporter inhibitor, is effective for the treatment of chronic kidney disease–mineral bone disorder. Kidney International 98:2, pages 343-354.
Crossref
Crossref
Linto Thomas, Jianxiang Xue, Sathish Kumar Murali, Robert A. Fenton, Jessica A. Dominguez Rieg & Timo Rieg. (2019) Pharmacological Npt2a Inhibition Causes Phosphaturia and Reduces Plasma Phosphate in Mice with Normal and Reduced Kidney Function. Journal of the American Society of Nephrology 30:11, pages 2128-2139.
Crossref
Crossref
Karolina Wieszczycka, Katarzyna Staszak, Marta J. Woźniak-Budych & Stefan Jurga. (2019) Lanthanides and tissue engineering strategies for bone regeneration. Coordination Chemistry Reviews 388, pages 248-267.
Crossref
Crossref
Aurelie Lenglet, Nicolas Fabresse, Méline Taupin, Cathy Gomila, Sophie Liabeuf, Said Kamel, Jean Claude Alvarez, Tilman B. Drueke & Ziad A. Massy. (2019) Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients?. Drugs 79:8, pages 855-862.
Crossref
Crossref
Mona S. Calvo, Richard A. Sherman & Jaime Uribarri. (2019) Dietary Phosphate and the Forgotten Kidney Patient: A Critical Need for FDA Regulatory Action. American Journal of Kidney Diseases 73:4, pages 542-551.
Crossref
Crossref
Víctor Sorribas, Natalia Guillén & Cecilia Sosa. (2018) Substrates and inhibitors of phosphate transporters: from experimental tools to pathophysiological relevance. Pflügers Archiv - European Journal of Physiology 471:1, pages 53-65.
Crossref
Crossref